New combo therapy aims to shrink rectal tumors faster
NCT ID NCT07669220
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new treatment approach for high-risk rectal cancer: short-course radiation followed by immunotherapy (toripalimab) and chemotherapy (FOLFOX) versus the standard long-course chemoradiation. The goal is to see if the new approach leads to more complete tumor responses and better long-term outcomes. The trial plans to enroll 76 adults with a specific type of rectal cancer that has not spread widely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Toripalimab (a PD-1 inhibitor) combined with FOLFOX chemotherapy
- What this could lead to
- If successful, this could offer a more effective and less toxic treatment option for high-risk rectal cancer, potentially reducing the need for major surgery.
- What could go wrong
- This is a small, early-phase (Phase 2) trial with only 76 participants, so results may not apply to everyone. The combination therapy may cause significant side effects, and it's not yet proven to be better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLFOX are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Sixth Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can diet and vitamin c supercharge rectal cancer treatment?
- AI as a surgical Co-Pilot: predicting difficulty in rectal cancer
- A new radiation combo may spare the rectum in early cancer
- Can an AI coach and simple exercises help cancer patients fight frailty?
- Can a triple-drug cocktail after short radiation eliminate rectal cancer without surgery?
- Metabolic MRI may reveal hidden cancer responses and spare patients from surgery